1. Stocks
    2. /
  2. Global X S&P Biotech ETF (ASX: CURE)
    3. /

Global X S&P Biotech ETF (ASX: CURE) Share Price and News

Price

 

Movement

   

  (20 mins delayed)

52 Week Range

  -  

 
1 Year Return

 

Global X S&P Biotech ETF Chart and Price Data

Fundamentals Data provided by Morningstar.

Share Price

Day Change

52 Week Range

-

Yesterday's Close

Today's Open

Days Range

-

Volume

Avg. Volume (1 month)

Turnover

as at 24 Feb 3:44pm

    • Global X S&P Biotech ETF (ASX: CURE)
    Latest News

    two young men sit side by side with gaming controllers pumping their fists and celebrating with joyous looks on their faces at their achievements in the video game they are playing.
    Exchange-Traded Funds (ETFs)

    3 ASX ETFs to target in the new year – the booming themes of 2025

    | Aaron Bell

    Does your portfolio include exposure to these emerging themes?

    Read more »

    A elder man and woman lean over their balcony with a cuppa, indicating share rpice movement for ASX retirement shares
    Exchange-Traded Funds (ETFs)

    The long game: ASX ETFs to target amidst an ageing population

    | Aaron Bell

    These funds could be set to benefit from increased demand in global healthcare. 

    Read more »

    Value spelt out with a magnifying glass.
    Exchange-Traded Funds (ETFs)

    3 ASX ETFs that could be good value right now

    | Aaron Bell

    Investors looking for a bargain might consider these international funds. 

    Read more »

    ETF written in yellow with a yellow underline and the full word spelt out in white underneath.
    Exchange-Traded Funds (ETFs)

    2 top ETFs for ASX investors to buy in October

    | James Mickleboro

    These ETFs could be top options for investors in October...

    Read more »

    A young woman sits with her hand to her chin staring off to the side thinking about her investments.
    Exchange-Traded Funds (ETFs)

    2 exciting ETFs named as buys by experts

    | James Mickleboro

    Here are two ETFs that could be buys...

    Read more »

    CURE ASX Announcements

    An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.

    DateAnnouncementPrice Sensitive?TimeNo. of PagesFile Size
    YesNo

    Directors & Management Data provided by Morningstar.

    Data provided by Morningstar.
    Name Title Start Date Profile
    Mr Young Kim Non-Executive Director Jun 2022
    No Profile Reported in Last Annual Report.
    Mr Namki Kim Non-Executive Director Jul 2024
    No Profile Reported in Last Annual Report.
    Mr Alexandre Zaika Non-Executive Director Dec 2024
    No Profile Reported in Last Annual Report.
    Mr Krzysztof Wolak Non-Executive Director Feb 2025
    No Profile Reported in Last Annual Report.

    Top Shareholders Data provided by Morningstar.

    Data provided by Morningstar.
    Name Shares Capital
    No top 20 shareholder's information disclosed 0 0.00%

    Profile

    since

    Note